03675nam 2200709 450 99620865940331620230721004930.01-283-51409-597866138265411-4443-0020-21-4443-0021-0(CKB)1000000000715925(EBL)416368(SSID)ssj0000112114(PQKBManifestationID)11819483(PQKBTitleCode)TC0000112114(PQKBWorkID)10081240(PQKB)10357910(MiAaPQ)EBC416368(OCoLC)352745598(EXLCZ)99100000000071592520160805h20082008 uy 0engur|n|---|||||txtccrBiomarkers in heart disease /edited by James A. de LemosMalden, Massachusetts :Blackwell Publishing,2008.©20081 online resource (252 p.)AHA Clinical Series"American Heart Association."1-4051-7571-0 Includes bibliographical references and index.Contents; Contributors; Preface; Foreword; PART I Biomarkers for the Evaluation of Patients with Ischemic Heart Disease; 1 Protocols for diagnosing myocardial infarction; 2 Troponin and other markers of necrosis for risk stratification in patients with acute coronary syndromes; 3 Challenges interpreting cardiac troponin values; 4 Natriuretic peptides and inflammatory markers for risk stratification in patients with ischemic heart disease; 5 Novel markers in patients with suspected acute coronary syndromes; PART I I Biomarkers for Evaluation of Patients with Heart Failure6 Use of natriuretic peptides in the diagnosis of heart failure7 Biomarkers for risk stratification in patients with heart failure; 8 Natriuretic peptides for disease monitoring in patients with chronic heart failure; PART I I I Biomarkers for Screening in Ambulatory Populations; 9 C-Reactive Protein; 10 Newer markers for population screening: focus on lipoprotein-related markers; PART I V A Look to the Future; 11 Moving toward personalized medicine; IndexBiomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine. The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scenaAHA clinical series.DiseasesRisk factorsMethodsBiochemical markersHeartDiseasesDiagnosisHeartDiseasesHeartDiseasesMolecular diagnosisBiochemical markersDiagnostic useDiseasesRisk factorsBiochemical markers.HeartDiseasesDiagnosis.HeartDiseases.HeartDiseasesMolecular diagnosis.Biochemical markersDiagnostic use.616.1/2075616.12075de Lemos JamesAmerican Heart Association.MiAaPQMiAaPQMiAaPQBOOK996208659403316Biomarkers in heart disease2186530UNISA